Noninfectious Intermediate, Posterior, or Panuveitis: Results from the Retrospective, Observational, International EyeCOPE Study.

Michal KramerMichaela BrichovaIlknur Tugal-TutkunMykola PanchenkoNatali GormezanoFranziska KoenigsbauerPablo FrancoCristina MuccioliMurat Hasanreisoğlunull null

Published in: Ophthalmology and therapy (2021)

Despite treatment, most patients with NIIPPU experienced a decline in ocular function and ocular complications. There is an unmet need for additional NIIPPU treatment, such as targeted monoclonal antibodies.

Keyphrases

cross sectional
risk factors
combination therapy
replacement therapy